Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Hyperferritinemia associated with increased illness severity in COVID-19

Yehuda Shoenfeld is the world's leading expert in the research, treatment and prevention of autoimmune diseases.

22 Apr 2020

Antibodies to COVID-19 present in only 2 to 3 percent of population

This week on Monday (20th April 2020), in a press meet, the World Health Organization (WHO) Director-General said that only around 2 to 3 percent of the global population have antibodies that show they had been infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes COVID-19 disease.

22 Apr 2020

New heart attack testing protocol can reduce wait times and overcrowding in ERs

A new protocol using highly sensitive blood tests to determine whether someone is having a heart attack can reduce wait times and overcrowding in emergency departments, according to a new study from UT Southwestern Medical Center.

22 Apr 2020

Scientists identify cells likely targeted by novel coronavirus

Researchers at MIT; the Ragon Institute of MGH, MIT, and Harvard; and the Broad Institute of MIT and Harvard; along with colleagues from around the world have identified specific types of cells that appear to be targets of the coronavirus that is causing the Covid-19 pandemic.

22 Apr 2020

Computers join the battle against novel coronavirus

Scientists everywhere are banding together to fight the novel coronavirus, and they're already making progress.

22 Apr 2020

Should age be a prioritizing factor in deciding who gets treated for COVID-19?

With pubic healthcare systems becoming increasingly strained due to the impact of COVID-19, healthcare professionals are having to question whether to factor age in as a priority when deciding who to treat.

22 Apr 2020

Individualized vent-splitter may allow multiple COVID-19 patients to share single ventilator

As the pandemic swept across the nation in March, so did urgent questions about the virus' potential strain on the healthcare system.

22 Apr 2020

COVID-19 unlikely to be transmitted through semen, study shows

COVID-19 is unlikely to be spread through semen, according to University of Utah Health scientists who participated in an international study of Chinese men who recently had the disease.

22 Apr 2020

The other COVID risks: How race, income, zip code influence who lives or dies

It started with a headache in late March. Then came the body aches.

22 Apr 2020

OSHA probing health worker deaths but urges inspectors to spare the penalties

The Occupational Safety and Health Administration has in recent weeks launched investigations into deaths of workers at 34 health care employers across the U.S., federal records show, but former agency officials warn that the agency has already signaled it will only cite and fine the most flagrant violators.

22 Apr 2020

A first-in-human trial with promising MERS coronavirus vaccine

Over the past 20 years, coronaviruses have been responsible for large outbreaks, resulting in severe respiratory illness and a number of deaths.

22 Apr 2020

In the middle of the country, a hospital and its community prepare for the surge

Megan Kampling and her husband were only a few days into a spring break trip with their children when Kansas Gov. Laura Kelly shut down schools in an effort to slow the spread of the novel coronavirus.

22 Apr 2020

UK and US companies lag behind other nations in rolling out COVID-19 diagnostic tests

Nations with high rates of coronavirus testing such as South Korea and Germany are also leading the world in commercialising COVID-19 diagnostic tests - far outstripping the domestic UK and US diagnostic industries, new research shows.

22 Apr 2020

Coronavirus fuels explosive growth in telehealth ― and concern about fraud

On March 17, Medicare chief Seema Verma stepped to the podium at a White House coronavirus briefing and unveiled a "historic action" to promote virtual medical care, or telehealth.

22 Apr 2020

Avacta successfully generates several highly specific Affimer reagents for COVID-19 antigen rapid test ahead of schedule as part of Cytiva partnership

Avacta Group plc is pleased to announce that it has successfully generated multiple Affimer reagents that bind the SARS-COV-2 viral antigen.

From Avacta Life Sciences Ltd. 22 Apr 2020

Scripps Research established international network to find antiviral compounds against COVID-19

With the COVID-19 pandemic continuing to spread around the globe, Scripps Research has quickly established an international network of collaborating scientific laboratories to leverage ReFRAME, the world's leading drug repurposing collection, to find antiviral compounds against the novel coronavirus.

22 Apr 2020

Navy offers protective gear to first responders to fight coronavirus

To equip those on the front lines of coronavirus response, the Naval Undersea Warfare Center (NUWC) Division Keyport--in partnership with the U.S. Navy's Tech Bridge program--manufactured over 500 face shields and personal protection equipment for first responders at two hospitals and naval commands in the state of Washington.

22 Apr 2020

Nanoengineers are using plant virus to develop COVID-19 vaccine

Nanoengineers at the University of California San Diego are working on a COVID-19 vaccine using an unconventional candidate: a plant virus.

22 Apr 2020

Facebook helps coronavirus fight by mapping symptoms

Facebook just rolled out an interactive map showing how many people have reported symptoms of coronavirus disease (COVID-19) in counties across the United States. The map helps to determine the extent of the coronavirus pandemic in the country, providing insight into the areas needing more resources and which parts can be reopened.

22 Apr 2020

Scientists identify new mechanisms that offer protection against Marburg infection

A detailed study of the monoclonal antibodies from a person who survived a Marburg infection led researchers to identify novel mechanisms that contribute protection against the disease, according to the latest findings of a collaborative team led by The University of Texas Medical Branch at Galveston and Vanderbilt University Medical Center.

22 Apr 2020